Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Clinical Chemistry
|
September 26, 2006
Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother
David J Halsall, Michael N Fahie-Wilson, S Kate Hall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 2019
Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β
Karn Wejaphikul, Stefan Groeneweg, Yvonne Hilhorst-Hofstee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 21, 2010
Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism
Mireille Castanet, Uma Mallya, Maura Agostini, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 27, 2018
Role of Leucine 341 in Thyroid Hormone Receptor Beta Revealed by a Novel Mutation Causing Thyroid Hormone Resistance
Karn Wejaphikul, Stefan Groeneweg, Prapai Dejkhamron, et al.
European Journal of Endocrinology
|
March 11, 2016
The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone β Receptor pathway
Laura P B Elbers, Carla Moran, Victor Ea Gerdes, et al.
Diabetes
|
April 28, 2005
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma
Ulf Risérus, Garry D Tan, Barbara A Fielding, et al.
Clinical Chemistry
|
March 14, 2009
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge
David Cartwright, Paula O'Shea, Odelia Rajanayagam, et al.
Endocrinology
|
December 6, 2003
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
Maura Agostini, Mark Gurnell, David B Savage, et al.
Diabetes
|
September 28, 2006
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice
Sarah L Gray, Edoardo Dalla Nora, Johannes Grosse, et al.
European Thyroid Journal
|
October 29, 2025
Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutation
Ferdy S van Geest, Wenjun Liao, Paul G Voorhoeve, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Clinical Chemistry
|
September 26, 2006
Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother
David J Halsall, Michael N Fahie-Wilson, S Kate Hall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 2019
Insight Into Molecular Determinants of T3 vs T4 Recognition From Mutations in Thyroid Hormone Receptor α and β
Karn Wejaphikul, Stefan Groeneweg, Yvonne Hilhorst-Hofstee, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 21, 2010
Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism
Mireille Castanet, Uma Mallya, Maura Agostini, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 27, 2018
Role of Leucine 341 in Thyroid Hormone Receptor Beta Revealed by a Novel Mutation Causing Thyroid Hormone Resistance
Karn Wejaphikul, Stefan Groeneweg, Prapai Dejkhamron, et al.
European Journal of Endocrinology
|
March 11, 2016
The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone β Receptor pathway
Laura P B Elbers, Carla Moran, Victor Ea Gerdes, et al.
Diabetes
|
April 28, 2005
Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma
Ulf Risérus, Garry D Tan, Barbara A Fielding, et al.
Clinical Chemistry
|
March 14, 2009
Familial dysalbuminemic hyperthyroxinemia: a persistent diagnostic challenge
David Cartwright, Paula O'Shea, Odelia Rajanayagam, et al.
Endocrinology
|
December 6, 2003
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
Maura Agostini, Mark Gurnell, David B Savage, et al.
Diabetes
|
September 28, 2006
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice
Sarah L Gray, Edoardo Dalla Nora, Johannes Grosse, et al.
European Thyroid Journal
|
October 29, 2025
Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutation
Ferdy S van Geest, Wenjun Liao, Paul G Voorhoeve, et al.
Page
of 3